With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...

The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...

Aldeyra Therapeutics Inc. ALDX shares are tumbling on Tuesday following the U.S. Food and Drug Administration (FDA) update.

Shares of Aldeyra Therapeutics ALDX plunged 70.7% on Tuesday after the company announced receiving a Complete Response Letter ...

In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...

More than 360 million people around the world suffer from dry eye disease, which is characterized by chronically red, scratchy or irritated eyes. blackday - stock.adobe.com Dry eye disease is no ...

Adults with a deficiency of vitamin D are at increased risk for developing dry eye disease than those without low levels of the nutrient, a study finds.

Most people don't spend much time thinking about their eyes until there's a problem — and then it's hard to think of anything else. Dry eye disease is one of those issues that's hard to ignore, ...

After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...

Last October, when Talia Rotenberg was traveling to Europe, her eyes became bloodshot, watery, and painful—the same feeling she would expect if she had a torn contact lens in her eye. She was baffled, ...

Dry eye seems to be a straightforward disease—a physical lack of tears resulting in discomfort that is remedied by lubricants. In reality, dry eye disease is a multifactorial condition that follows a ...